Latest Articles
Head of New RFK Jr. Vaccine Study Practiced Unlicensed Medicine on Autistic Kids - The 74
Head of New RFK Jr. Vaccine Study Practiced Unlicensed Medicine on Autistic Kids The 74
Published: April 11, 2025, 8:19 p.m.
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer - HMP Global Learning Network
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer HMP Global Learning Network
Published: April 11, 2025, 2:54 p.m.
‘I had to plan my life around pain’ – Donegal woman diagnosed with Endometriosis forced to leave Ireland for treatment - The Irish Independent
‘I had to plan my life around pain’ – Donegal woman diagnosed with Endometriosis forced to leave Ireland for treatment The Irish Independent
Published: April 10, 2025, 12:39 p.m.
Donegal woman diagnosed with Endometriosis forced to leave Ireland for treatment: “I had to plan my life around pain” - The Irish Independent
Donegal woman diagnosed with Endometriosis forced to leave Ireland for treatment: “I had to plan my life around pain” The Irish Independent
Published: April 10, 2025, 12:39 p.m.
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma - MedPage Today
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma MedPage Today
Published: April 9, 2025, 3:15 p.m.
Teenager forced to use walker, wheelchair because of endometriosis pain - The Irish Times
Teenager forced to use walker, wheelchair because of endometriosis pain The Irish Times
Published: April 9, 2025, 1:17 p.m.
Dual PD-1/CTLA-4 Inhibition With Cadonilimab Plus Lenvatinib Yields Disease Control in Advanced Endometrial Cancer - OncLive
Dual PD-1/CTLA-4 Inhibition With Cadonilimab Plus Lenvatinib Yields Disease Control in Advanced Endometrial Cancer OncLive
Published: April 8, 2025, 1:11 p.m.
Key Factors Influencing IO Continuation or Discontinuation in Subsequent Lines of Treatment in Advanced EC - OncLive
Key Factors Influencing IO Continuation or Discontinuation in Subsequent Lines of Treatment in Advanced EC OncLive
Published: April 7, 2025, 4:02 p.m.
Guiding Treatment Decisions Post-IO in Advanced EC: Insights from Available Data - OncLive
Guiding Treatment Decisions Post-IO in Advanced EC: Insights from Available Data OncLive
Published: April 7, 2025, 12:22 p.m.
Pacific Institute of Medical Sciences, Udaipur Launches Rajasthan’s First Advanced Neurobiofeedback Therapy Center - Udaipur Kiran
Pacific Institute of Medical Sciences, Udaipur Launches Rajasthan’s First Advanced Neurobiofeedback Therapy Center Udaipur Kiran
Published: April 4, 2025, 4:39 p.m.
Link copied to clipboard!